ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VYNE VYNE Therapeutics Inc

2.96
0.01 (0.34%)
29 Nov 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 167k6k99k135k114k76k98k198k
Operating Income -9.33M-7.98M-5.88M-10.32M-6.23M-6.83M-7.38M-10.4M
Pre Tax Income -9.26M-7.75M-5.61M-10.04M-6.07M-6.15M-6.24M-9.4M
Net Income -9.46M-9.95M-5.62M-10.06M-6.58M-6.19M-6.25M-9.41M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -9.26M-7.75M-5.61M-10.04M-6.07M-6.15M-6.24M-9.4M
EBITDA -9.16M-8.14M-5.88M-10.32M-6.23M-6.83M-7.38M-10.4M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 674k4.58M10.64M020.99M14.76M477k424k
Operating Income -14.33M-29.59M-54.54M-76.24M-198.2M-68.03M-34.3M-29.26M
Pre Tax Income -14.07M-29.08M-51.45M-73.7M-255.83M-73.78M-33.93M-27.87M
Net Income -14.07M-29.08M-51.45M-73.7M-255.83M-73.33M-23.21M-28.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.664-5.487-2.214-3.02-5.921-1.369-7.186-2.039
EBIT -14.33M-29.59M-54.54M-76.24M-197.09M-68.17M-33.93M-27.87M
EBITDA -14.33M-29.59M-54.51M-76.19M-197.86M-67.93M-34.22M-29.26M